Jordan R Hansford

46PUBLICATIONS
479CO-AUTHORS
Molecular targetsPredictive and prognostic markersCardiovascular medicine and haematology not elsewhere classifiedCancer geneticsCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|May 19, 2026
Precision-guided therapy in H3K27-altered diffuse midline glioma.

|May 12, 2026
Balancing Risk, Benefit, and Reality: Navigating Early Phase Studies in Pediatric Diffuse Midline Glioma.

|Mar 09, 2026
Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.

Cameron Crowell, Nikhil P Mankuzhy, Julie Bennett

|Feb 13, 2026
Integrated Germline and Somatic Molecular Profiling to Detect Cancer Predisposition Has a High Clinical Impact in Poor-Prognosis Pediatric Cancer.

Noemi A Fuentes-Bolanos, Eliza Courtney, Chelsea Mayoh

|Aug 26, 2025
Peripheral blood DNA methylation predicts the early onset of primary tumor in TP53 mutation carriers.

Vallijah Subasri, Benjamin Brew, Brianne Laverty

|Apr 16, 2025
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

Lindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford

Pageof 8

Frequent Collaborators

11 joint publications

Nicholas G Gottardo

9 joint publications

David S Ziegler

9 joint publications

Dong-Anh Khuong-Quang

8 joint publications

Uri Tabori